drugset / Trial / NCT03336593
Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is to assess protectivity and safety of Quadrivalent Influenza Vaccine in Indonesian Population
Timeline
- Start
- 2017-11-21
- Primary completion
- 2018-03-14
- Completion
- 2018-11-30
Publications
- Fadlyana E, Dhamayanti M, Tarigan R, Prodjosoewojo S, Rahmadi AR, Sari RM, Rusmil K, Kartasasmita CB. Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults. PLoS One. 2023 Aug 24;18(8):e0281566. doi: 10.1371/journal.pone.0281566. eCollection 2023.
- Dhamayanti M, Tarigan R, Fadlyana E, Prasetyo D, Amalia N, Rusmil VK, Sari RM, Bachtiar NS, Rusmil K, Kartasasmita CB. Immunogenicity and safety of Quadrivalent Influenza HA vaccine in Indonesian children: An open-labeled, bridging, clinical study. Vaccine. 2020 Jan 29;38(5):993-1000. doi: 10.1016/j.vaccine.2019.12.008. Epub 2019 Dec 17.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quadrivalent influenza vaccine | Vaccine | 0.25 ml | — |
| Subject | Quadrivalent influenza vaccine | Vaccine | 0.5 ml | — |
| Comparator | Trivalent Influenza Vaccine | Vaccine | 0.5 ml | — |
Indications
No indication recorded.